Literature DB >> 32146658

Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema.

Ali Sepehrinezhad1, Asadollah Zarifkar2, Gholamreza Namvar3, Ali Shahbazi4,5, Roger Williams6,7.   

Abstract

Hepatic encephalopathy (HE) may occur in patients with liver failure. The most critical pathophysiologic mechanism of HE is cerebral edema following systemic hyperammonemia. The dysfunctional liver cannot eliminate circulatory ammonia, so its plasma and brain levels rise sharply. Astrocytes, the only cells that are responsible for ammonia detoxification in the brain, are dynamic cells with unique phenotypic properties that enable them to respond to small changes in their environment. Any pathological changes in astrocytes may cause neurological disturbances such as HE. Astrocyte swelling is the leading cause of cerebral edema, which may cause brain herniation and death by increasing intracranial pressure. Various factors may have a role in astrocyte swelling. However, the exact molecular mechanism of astrocyte swelling is not fully understood. This article discusses the possible mechanisms of astrocyte swelling which related to hyperammonia, including the possible roles of molecules like glutamine, lactate, aquaporin-4 water channel, 18 KDa translocator protein, glial fibrillary acidic protein, alanine, glutathione, toll-like receptor 4, epidermal growth factor receptor, glutamate, and manganese, as well as inflammation, oxidative stress, mitochondrial permeability transition, ATP depletion, and astrocyte senescence. All these agents and factors may be targeted in therapeutic approaches to HE.

Entities:  

Keywords:  Ammonia; Astrocyte swelling; Cytotoxic edema; Hepatic encephalopathy; Liver failure

Mesh:

Substances:

Year:  2020        PMID: 32146658     DOI: 10.1007/s11011-020-00549-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  7 in total

Review 1.  Hyperammonemia in Inherited Metabolic Diseases.

Authors:  Graziela Schmitt Ribas; Franciele Fátima Lopes; Marion Deon; Carmen Regla Vargas
Journal:  Cell Mol Neurobiol       Date:  2021-10-19       Impact factor: 4.231

2.  Time-lapse imaging using dual-color coded quantitative differential phase contrast microscopy.

Authors:  Ying-Ju Chen; Yu-Zi Lin; Sunil Vyas; Tai-Horng Young; Yuan Luo
Journal:  J Biomed Opt       Date:  2022-05       Impact factor: 3.758

3.  Curcumin prevents cognitive deficits in the bile duct ligated rats.

Authors:  Somayeh Baghbaderani; Mehrdad Hashemi; Mohaddaseh Ebrahimi-Ghiri; Mohammad-Reza Zarrindast; Mohammad Nasehi; Maliheh Entezari
Journal:  Psychopharmacology (Berl)       Date:  2020-08-06       Impact factor: 4.530

4.  Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice.

Authors:  Long Cheng; Xiaoying Wang; Xueni Ma; Huimei Xu; Yifan Yang; Dekui Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 5.  The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis.

Authors:  So Yeong Cheon; Juhyun Song
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

6.  Evaluation of the protective effect of curcumin on encephalopathy caused by intrahepatic and extrahepatic damage in male rats.

Authors:  Forouzan Frozandeh; Nader Shahrokhi; Mohammad Khaksari; Sedigheh Amiresmaili; Gholamreza AsadiKaram; Nava Shahrokhi; Maryam Iranpour
Journal:  Iran J Basic Med Sci       Date:  2021-06       Impact factor: 2.699

7.  Astrocytes profiling in acute hepatic encephalopathy: Possible enrolling of glial fibrillary acidic protein, tumor necrosis factor-alpha, inwardly rectifying potassium channel (Kir 4.1) and aquaporin-4 in rat cerebral cortex.

Authors:  Dalia Mahmoud Abdelmonem Elsherbini; Fatma M Ghoneim; Eman Mohammed El-Mancy; Hasnaa Ali Ebrahim; Mohamed El-Sherbiny; Mohamed El-Shafey; Rasha Hamed Al-Serwi; Nehal M Elsherbiny
Journal:  Front Cell Neurosci       Date:  2022-08-17       Impact factor: 6.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.